Abstract
Animal bioassays for carcinogens depend on evaluation of morphologic changes in affected organs following carcinogen exposure. In rats and mice this procedure is expensive, and evaluation of the morphologic changes that occur before obvious cancer develops are subject to disagreement among pathologists. In particular, the reversible morphologic changes that occur in the liver upon exposure to chemical hepatocarcinogens have been given different interpretations by different pathologists (1–5). Terms used vary from “preneoplastic,” implying a lesion that will eventually develop into a cancer, to “hyperplastic” or “benign proliferative lesion,” which implies that it does not develop into cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Farber, E. (1973) Meth. Cancer Res. 7:345.
Squire, R.A., and M.H. Levitt (1975) Cancer Res. 35:3214.
Schueler, R.L., et al. (1980) Proceedings of a Mouse Liver Tumor Workshop, Silver Spring, Maryland, June 11–13.
Becker, F.F. (1982) Cancer Res. 42:3918.
Sell, S., and H.L. Leffert (1982) Hepatology 2:77.
Farber, E., et. al. (1979) In Carcinogens: Identification and Mechanisms of Action, A.C. Griffin and C.R. Shaw, eds. Raven Press, New York, p. 319.
Ames, B.N., W.E. Durston, E. Yamasaki, and F.D. Lee (1973) Proc. Natl. Acad. Sci., USA 70:2281.
Heidelberger, C. (1973) Adv. Cancer Res. 18:317.
Skehan, P., and S.J. Friedman (1981) In The Transformed Cell, Academic Press, New York, pp. 7–65.
Sell, S. (1980) Cancer Markers, Vol. I, Humana Press, Clifton, New Jersey.
Sell, S., and B. Wahren, eds. (1982) Cancer Markers, Vol. II, Humana Press, Clifton, New Jersey.
Sell, S., F.F. Becker, B. Lombardi, H. Shinozuka, and J. Reddy(1979) In Carcino-Embryonic Proteins, Vol. I, F.-G. Lehmann, ed. Elsevier/North Holland Biomed. Press, p. 129.
Kinosita, R. (1937) Trans. Soc. Path. Jap. 27:665.
Farber, E. (1956) Cancer Res. 16:142.
Reuber, M.D. (1965) J. Natl. Cancer lnst. 34:697.
Teebor, G.W., and F.F. Becker (1971) Cancer Res. 31:1.
Becker, F.F., and S. Sell (1974) Cancer Res. 34:2489.
DeBaun, J.R., E.C. Miller, and J.A. Miller (1970) Cancer Res. 30:577.
Gutmann, H.R., D. Malejka-Giganti, E.J. Barry, and R.E. Rydell (1972) Cancer Res. 32:1554.
Jackson, C.D., and C.C. Irving (1972) Cancer Res. 32:1590.
Becker, F.F., and S. Sell (1979) Cancer Res. 39:1437.
Leffert, H.L., and D. Paul (1973) J. Cell. Physiol. 81:113.
Sell, S., H.L. Leffert, H. Skelly, V. Muller-Eberhard, and S. Kida (1975) Ann. N.Y. Acad. Sci. 259:45.
Koch, K.S., and H.L. Leffert (1980) Ann. N.Y. Acad. Sci. 349:111.
Sell, S. (1978) Cancer Res. 38:3107.
Lombardi, B., and H. Shinozuka (1979) Int. J. Cancer 23:565.
Shinozuka, H., B. Lombardi, S. Sell, and R.M. Iammarino (1978) J. Natl. Cancer. Inst. 61:813.
Shinozuka, H., M.A. Sells, S.L. Katyal, S. Sell, and B. Lombardi (1979) Cancer Res. 39:2515.
Sell, S., H.L. Leffert, H. Shinozuka, B. Lombardi, and N. Gochman (1981) Gann 72:479.
Sell, S., K. Osborn, and H.L. Leffert (1981) Carcinogenesis 2:7.
Sell, S., and E. Ruoslahti (1982) J. Natl. Can. Inst. 69:1105.
Sarcione, E. (1972) In Embryonic and Fetal Antigens in Cancer, Vol 2, N.G. Anderson, J.N. Coggin, E. Cole, and J.W. Hallerman, eds. Oak Ridge National Laboratory, Oak Ridge, Tennessee, pp. 323–328.
Hudig, D., S. Sell, L. Newell, and F.F. Becker (1979) Cancer Res. 39:3715.
Shinozuka, H., B. Lombardi, S. Sell, and R.M. Iammarino (1978) Cancer Res. 38:1092.
Shinozuka, H., B. Lombardi, S. Sell, R.M. Iammarino (1978) J. Natl. Cancer Inst. 61:813.
Becker, F.F., A.A. Horland, A. Shurgin, and S. Sell (1975) Cancer Res. 35:1510.
Shinozuka, H., M.A. Sells, S.L. Katyal, S. Sell, and B. Lombardi (1979) Cancer Res. 39:2515.
Reddy, J.K., M.S. Rao, D.L. Azarnoff, and S. Sell (1979) Cancer Res. 39:152.
Grisham, J.W., and W.S. Hartroft (1961) Lab. Investig. 10:317.
Schaffner, F., and H. Popper (1961) Am. J. Pathol. 38:393.
Grisham, J.W., and E.A. Porta (1964) Exp. Mal. Path. 3:242.
Fukusmima, S., M. Shibata, T. Hibino, T. Yoshimura, M. Hirose, and N. Ito (1979) Toxicol. App. Pharm. 48:145.
Sell, S. (in press) Cancer Res.
Becker, F.F., D. Stillman, and S. Sell (1977) Cancer Res. 37:870.
Jalanko, H., I. Virtauen, E. Engvall, and E. Ruoslahti (1978) Int. J. Cancer 21:453.
Becker, F.F. and S. Sell (1979) Cancer Res. 39:3491.
Jalanko, H., and E. Ruoslahti (1979) Cancer Res. 39:3495.
Princler, G.L., G. Vlahakis, K.H. Kortright, S. Okada, and K.R. McIntire (1981) Eur. J. Cancer Clin. Oncol. 17:1241.
Shinozuka, H., S.L. Katyal, and B. Lombardi (1978) Int. J. Cancer 22:36.
Boyd, J.N., N. Misslbeck, J.G. Babish, T.C. Campbell, and G.S. Stoewsand (1981) Drug. Chem. Tox. 4:197.
Sala-Trepat, J.M., T.D. Sargent, S. Sell, and J. Bonner (1979) Proc. Natl. Acad. Sci., USA 76:695.
Sell, S., K. Thomas, M. Michaelsen, J. Sala-Trepat, and J. Bonner (1979) Biochem. Biophys. Acta 564:173.
Sala-Trepat, J.M., J. Dever, T.D. Sargent, K. Thomas, S. Sell, and J. Bonner (1979) Biochemistry 18:2167.
Nahon, J.-L., A. Gal, M. Franin, S. Sell, and J.M. Sala-Trepat (1982) Nucleic Acids Res. 10:1895.
Sell, S., J. Sala-Trepat, T. Sargent, K. Thomas, J.-L. Nahon, T. Goodman, and J. Bonner (1980) Cell BioI. Int. Reports 4:235
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Sell, S. et al. (1983). Alphafetoprotein as a Marker for Early Events and Carcinoma Development During Chemical Hepatocarcinogenesis. In: Milman, H.A., Sell, S. (eds) Application of Biological Markers to Carcinogen Testing. Environmental Science Research, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3790-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3790-4_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3792-8
Online ISBN: 978-1-4613-3790-4
eBook Packages: Springer Book Archive